KD Logo

An Analysis of Pfizer Inc (PFE)’s Potential Price Growth

Pfizer Inc’s filing revealed that its Director Gottlieb Scott acquired Company’s shares for reported $28240.0 on Oct 30 ’24. In the deal valued at $28.24 per share,1,000 shares were bought. As a result of this transaction, Gottlieb Scott now holds 10,000 shares worth roughly $0.26 million.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Then, DAMICO JENNIFER B. sold 5,154 shares, generating $147,714 in total proceeds. Upon selling the shares at $28.66, the SVP & Controller now owns 8,582 shares.

Before that, Gottlieb Scott bought 3,000 shares. Pfizer Inc shares valued at $79,401 were divested by the Director at a price of $26.47 per share. As a result of the transaction, Gottlieb Scott now holds 9,000 shares, worth roughly $0.24 million.

A number of analysts have revised their coverage, including Bernstein’s analysts, who began to cover the stock in mid October with a ‘”a Mkt perform”‘ rating. Daiwa Securities also remained covering PFE and has increased its forecast on August 07, 2024 with a “an Outperform” recommendation from previously “Neutral” rating. Argus revised its rating on March 22, 2024. It rated PFE as “a Hold” which previously was an “a Buy”.

Price Performance Review of PFE

On Tuesday, Pfizer Inc [NYSE:PFE] saw its stock fall -0.19% to $26.19. Over the last five days, the stock has lost -6.43%. Pfizer Inc shares have fallen nearly -9.03% since the year began. Nevertheless, the stocks have fallen -11.16% over the past one year. While a 52-week high of $31.54 was reached on 07/30/24, a 52-week low of $25.20 was recorded on 04/26/24. SMA at 50 days reached $28.80, while 200 days put it at $28.17.

Levels Of Support And Resistance For PFE Stock

The 24-hour chart illustrates a support level at 25.95, which if violated will result in even more drops to 25.70. On the upside, there is a resistance level at 26.44. A further resistance level may holdings at 26.68. The Relative Strength Index (RSI) on the 14-day chart is 25.13, which indicates oversold technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -1.41, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 92.55%. Stochastics %K at 2.85% indicates the stock is a buying.

How much short interest is there in Pfizer Inc?

A steep rise in short interest was recorded in Pfizer Inc stocks on 2024-10-15, dropping by -3.89 million shares to a total of 70.94 million shares. Yahoo Finance data shows the prior-month short interest on 2024-09-13 was 74.84 million shares. There was a decline of -5.49%, which implies that there is a negative sentiment for the stock.

The most recent change occurred on February 23, 2024 when Guggenheim began covering the stock and recommended ‘”a Buy”‘ rating along with a $36 price target.

Most Popular